‌

US Patent 11492371 Production of heterodimeric proteins

Patent 11492371 was granted and assigned to Genmab A/S on November, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Arnout F. Gerritsen0

Aran Frank Labrijn0

Amitava Kundu0

Werner L. Vos0

Paul Parren0

Patrick Van Berkel0

Patrick Priem0

Muriel Van Kampen0

...

Date of Patent

November 8, 2022

0

Patent Application Number

164266470

Date Filed

May 30, 2019

0

Patent Citations

US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof

0

US Patent 10906991 Bispecific antibodies and methods for production thereof

0

US Patent 10344050 Production of heterodimeric proteins

0

Patent Citations Received

US Patent 11858995 Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia

0

US Patent 11866514 Heterodimeric antibody Fc-containing proteins and methods for production thereof

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

The present invention relates to an in vitro method for production of heterodimeric proteins.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11492371 Production of heterodimeric proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.